VS
iShares Global Healthcare Index ETF (XHC) and Harvest Healthcare Leaders Income ETF (HHL) offer distinct profiles for Canadian ETF investors. A direct comparison shows that XHC focuses its top 3 sector exposures on Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals, while HHL leans towards Healthcare. When evaluating costs, XHC features a management fee (MER) of 0.63%, compared to 0.85% for HHL. Performance-wise, XHC has returned 3.4% year-to-date with -$45 M in net flows, whereas HHL is at 0.68% with +$351 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
XHC
HHL
| AuM | $529.21 M | $1,838.12 M |
| Management Fees | 0.63% | 0.85% |
| Exp. ratio | 0.66% | 0.98% |
| Tracking Difference | -0.02% | - |
Historical performance and flows
As of July 31, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | XHC | -1.44% | +9.91% | +3.40% | +20.74% | +17.09% |
HHL | +0.92% | +8.83% | -0.68% | +13.46% | +19.39% | |
| Flows | XHC | +$11 M | -$4 M | -$45 M | -$11 M | -$89 M |
HHL | +$25 M | +$114 M | +$351 M | +$411 M | +$700 M |
XHC vs HHL exposure
Countries
XHC
USA
69.39%
Switzerland
10.35%
Other
20.26%
HHL
USA
86.41%
Other
13.59%
Sectors
XHC
Healthcare
96.86%
HHL
Healthcare
101.57%
As of July 31, 2026
Top 10 Holdings
XHC
Eli Lilly & Co.
10.91%
Johnson & Johnson
7.03%
AbbVie, Inc.
5.11%
UnitedHealth Group, Inc.
4.39%
Merck & Co., Inc.
4.11%
AstraZeneca PLC
3.76%
Roche Holding AG
3.75%
Novartis AG
3.72%
Amgen, Inc.
2.53%
Thermo Fisher Scientific, Inc.
2.41%
HHL
Eli Lilly & Co.
5.44%
AbbVie, Inc.
5.44%
Johnson & Johnson
5.40%
Merck & Co., Inc.
5.38%
Vertex Pharmaceuticals, Inc.
5.38%
Amgen, Inc.
5.33%
Danaher Corp.
5.30%
UnitedHealth Group, Inc.
5.29%
Thermo Fisher Scientific, Inc.
5.25%
Novartis AG
5.23%
Diversification
XHC
Total weight of top 10 holdings out of 111 total
47.72%
HHL
Total weight of top 10 holdings out of 21 total
53.44%
Characteristics
Compare
XHC
HHL
| Provider | iShares | Harvest Portfolios Group |
| Management | Passively managed | Actively managed |
| Benchmark | S&P Global 1200 Health Care CAD Hedged Net Total Return Index - CAD | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 1.87% | 9.98% |
| Meets ESG criteria | No | No |
| Inception Date | April 12, 2011 | December 18, 2014 |
Frequently asked questions about XHC and HHL
Which ETF has performed better year to date: XHC or HHL?
As of July 31, 2026, XHC has returned 3.40% year to date, while HHL has returned -0.68%. XHC is ahead on YTD performance.
Which ETF is larger by assets under management: XHC or HHL?
As of July 31, 2026, XHC manages $529.21 M in assets, while HHL manages $1.84 B. HHL is the larger fund by AUM.
How are XHC and HHL managed?
XHC is passively managed by iShares. It tracks the S&P Global 1200 Health Care CAD Hedged Net Total Return Index - CAD benchmark. HHL is actively managed by Harvest Portfolios Group. It does not track an index.
What sectors do XHC and HHL emphasize?
XHC is most exposed to Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals. HHL is most exposed to Healthcare.
Which ETF is attracting more investor flows: XHC or HHL?
Year to date, XHC has seen -$45.40 M in net flows, compared with +$351.37 M for HHL. HHL has attracted more net investor money so far.
How do the fees of XHC and HHL compare?
XHC has an expense ratio of 0.66%, while HHL has an expense ratio of 0.98%.
What are the top holdings of XHC and HHL?
XHC's largest holdings include Eli Lilly & Co., Johnson & Johnson, and AbbVie, Inc.. HHL's top holdings include Eli Lilly & Co., AbbVie, Inc., and Johnson & Johnson.
Which ETF is more diversified: XHC or HHL?
XHC holds 110 securities, while HHL holds 21. On holdings count, XHC is the more diversified portfolio.
Recent articles about XHC and HHL
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.